Proteome Sciences (LON:PRM) Trading Down 11% – Here’s What Happened

Proteome Sciences plc (LON:PRM)’s stock price traded down 11% during trading on Wednesday . The stock traded as low as GBX 1.42 and last traded at GBX 1.42. 32,210 shares were traded during trading, a decline of 92% from the average session volume of 417,027 shares. The stock had previously closed at GBX 1.60.

Proteome Sciences Stock Up 16.7%

The firm’s fifty day moving average price is GBX 1.56 and its 200-day moving average price is GBX 1.94. The company has a market cap of £7.59 million, a price-to-earnings ratio of -2.08 and a beta of 0.07. The company has a current ratio of 0.13, a quick ratio of 0.37 and a debt-to-equity ratio of -165.46.

Proteome Sciences (LON:PRM) last posted its earnings results on Wednesday, April 15th. The company reported GBX (1.04) EPS for the quarter. The business had revenue of GBX 376 million for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.